Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV001535957 | SCV001752618 | likely pathogenic | Hypophosphatemic rickets, autosomal recessive, 1 | 2021-06-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001751790 | SCV001988038 | uncertain significance | not provided | 2019-09-30 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge |
Revvity Omics, |
RCV001535957 | SCV002017264 | likely pathogenic | Hypophosphatemic rickets, autosomal recessive, 1 | 2019-12-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001751790 | SCV002236880 | uncertain significance | not provided | 2022-08-04 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 4 of the DMP1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in DMP1 are known to be pathogenic (PMID: 16294270, 17033621, 19007919). This variant is present in population databases (rs141480996, gnomAD 0.5%). This variant has not been reported in the literature in individuals affected with DMP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1179102). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |